Radiation Oncology

Radiation oncology is a medical specialty that uses radiation therapy to treat cancer. The radiation therapy channel covers all aspects of radiation oncology technology. Radiation therapy includes linear accelerators (LINAC), proton therapy, brachytherapy, image guided radiation therapy (IGRT), focused ultrasound, stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), treatment planning systems and tomotherapy.

Data from Australia offers useful guidance for similar conditions in other advanced economies #lungcancer

Getty Images

News | Lung Imaging | April 22, 2020

Uptake of Lung Cancer Screening May Depend on Making Testing Fast and Convenient

April 22, 2020 — Value in Health, the official journal of ISPOR — the professional society for health economics and...

#gadolinium Guerbet announced that it received U.S. Food and Drug Administration (FDA) approval to manufacture Dotarem (gadoterate meglumine) injection at its Raleigh, N.C., facility

News | Interventional Radiology | April 21, 2020

Guerbet Announces FDA Approval to Manufacture Dotarem Injection in the United States

April 21, 2020 — Guerbet announced that it received U.S. Food and Drug Administration (FDA) approval to manufacture...

PTW announces first North American installation and FDA 510(k) clearance of Beamscan MR motorized 3-D water phantom

PTW Beamscan MR for Elekta Unity

News | Radiation Oncology | April 17, 2020

Beamscan MR Motorized 3-D Water Phantom Receives FDA Clearance

April 17, 2020 — PTW has installed the first Beamscan MR motorized 3-D water phantom in North America at the Princess...

Sponsored Content

Power injectors can improve efficiency and patient safety, for example, ensuring that contrast agent is not wasted due to the lack of a saline bolus. Image courtesy of Lior Molvin

Power injectors can improve efficiency and patient safety, for example, ensuring that contrast agent is not wasted due to the lack of a saline bolus. Image courtesy of Lior Molvin

Blog | Contrast Media | July 31, 2019

BLOG: How Advances in Technology Help Patients and Providers

Patient safety and operational efficiency are behind the development of modern contrast media, selection and...

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Professor David Sebag-Montefiore (Image courtesy of the University of Leeds)

Professor David Sebag-Montefiore (Image courtesy of the University of Leeds)

News | Radiation Therapy | April 07, 2020

Shorter Radiotherapy Treatment Recommended for Bowel Cancer Patients During COVID-19

April 7, 2020 — An international panel of cancer experts has recommended a one-week course of radiotherapy and delaying...

Eclipse v16 has received CE mark and is 510(k) pending

News | Proton Therapy | April 06, 2020

Varian Brings Machine Learning to Proton Treatment Planning

April 6, 2020 — Driven by its Intelligent Cancer Care approach in developing new solutions that use advanced...

Varian received FDA clearance for its Ethos therapy in February 2020. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Varian received FDA clearance for its Ethos therapy in February 2020, shown here displayed for the first time at ASTRO 2019. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Feature | Treatment Planning | April 03, 2020 | Dave Fornell, Editor

Artificial Intelligence Greatly Speeds Radiation Therapy Treatment Planning

The traditional treatment planning process takes days to create an optimized radiation therapy delivery plan, but new...

Collaboration offers clinicians a personalized oncology solution that combines cutting-edge MRI-guided radiation therapy with a leading AI-driven EMR integration platform

News | Radiation Oncology | April 01, 2020

ViewRay and VieCure Announce Strategic Collaboration to Accelerate Adoption of Personalized Cancer Care

April 1, 2020 — ViewRay, Inc. announced a strategic collaboration with VieCure, an artificial intelligence (AI)...

Women are more likely to be cured of cancer by radiotherapy but the side effects are worse.

Women are more likely to be cured of cancer by radiotherapy but the side effects are worse. Image by Mark Kostich

News | Radiation Therapy | March 30, 2020

A New Paper on the Pros and Cons of Radiotherapy

March 30, 2020 — Women undergoing radiotherapy for many cancers are more likely than men to be cured, but the side...

A new framework from an international team of experts aims to help protect patients and providers, and conserve protective equipment for frontline healthcare workers #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

News | Prostate Cancer | March 30, 2020

Managing Prostate Cancer Patients During the COVID-19 Pandemic

March 30, 2020 — In the wake of the COVID-19 pandemic, a team of radiation oncologists from the U.S. and U.K. is...

Novel scanners may open door for prognostic assessment in patients receiving cochlear implants

Iva Speck, MD, explains research showing that novel, fully digital, high-resolution positron emission tomography/computed tomography imaging of small brain stem nuclei can provide clinicians with valuable information concerning the auditory pathway in patients with hearing impairment. The research is featured in The Journal of Nuclear Medicine (read more at http://jnm.snmjournals.org/content/current). Video courtesy of Iva Speck, University Hospital Freiburg, Germany.

News | PET-CT | March 26, 2020

High-resolution PET/CT Assesses Brain Stem Function in Patients with Hearing Impairment

March 26, 2020 — Novel, fully digital, high-resolution positron emission tomography/computed tomography (PET/CT)...

PSMA PET-CT is a suitable replacement for conventional imaging, providing superior accuracy, to the combined findings of CT and bone scanning

News | Prostate Cancer | March 23, 2020

Prostate Cancer Study Finds Molecular Imaging Could Transform Management of Patients with Aggressive Cancer

March 23, 2020 — Results from a randomised controlled trial involving 300 prostate cancer patients find that a...

Age‐standardized, delay‐adjusted overall cancer incidence rates for 2012 through 2016 are illustrated among males and females by racial/ethnic group

Age‐standardized, delay‐adjusted overall cancer incidence rates for 2012 through 2016 are illustrated among males and females by racial/ethnic group. Racial/ethnic groups are mutually exclusive. Data for the non‐Hispanic American Indian/Alaska Native (AI/AN) population are restricted to Indian Health Service Purchased/Referred Care Delivery Area (PRCDA) counties. API indicates Asian/Pacific Islander. Chart courtesy of ACS Journals

News | Radiation Oncology | March 16, 2020

CDC Reports Cancer Death Rates Continue to Decline

March 16, 2020 — The Annual Report to the Nation on the Status of Cancer finds that cancer death rates continued to...

Reflexion eceived marketing clearance from the U.S. Food & Drug Administration (FDA) for stereotactic body radiotherapy (SBRT), stereotactic radiosurgery (SRS) and intensity modulated radiotherapy (IMRT) for its RefleXion X1 machine

News | Stereotactic Body Radiation Therapy (SBRT) | March 13, 2020

FDA Clearance Brings RefleXion Closer to Expanding Cancer Treatment Market

March 13, 2020 — RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (...

The guidance gives clarity and evidence to explain why the use of patient contact shielding to protect critical organs is no longer necessary for patients

News | Radiation Dose Management | March 13, 2020

BIR Offers Guidance on Why Patient Contact Shielding is no Longer Needed

March 13, 2020 — The British Institute of Radiology (BIR) and a working party of U.K. radiological professional bodies...

M. Minhaj Siddiqui, M.D., associate professor of surgery at the University of Maryland School of Medicine, discusses benefits of MRI-targeted biopsy to more precisely diagnose aggressive prostate cancers

M. Minhaj Siddiqui, M.D., associate professor of surgery at the University of Maryland School of Medicine, discusses benefits of MRI-targeted biopsy to more precisely diagnose aggressive prostate cancers. (c) University of Maryland Greenebaum Comprehensive Cancer Center

News | Prostate Cancer | March 05, 2020

Adding MRI-targeted Biopsy Leads to More Reliable Diagnosis of Aggressive Prostate Cancer

March 5, 2020 — Using a combination of magnetic resonance imaging (MRI) to target and sample suspicious prostate tissue...

Accuray Incorporated announced that Mercy Hospital St. Louis continues to demonstrate its commitment to improving patient outcomes with the installation of the first CyberKnife M6 System in Missouri at their state-of-the-art David C. Pratt Cancer Center

News | Stereotactic Body Radiation Therapy (SBRT) | February 27, 2020

First Accuray CyberKnife M6 System Installed in Missouri

February 27, 2020 — Accuray Incorporated announced that Mercy Hospital St. Louis continues to demonstrate its...

Sponsored Content | Videos | Artificial Intelligence | February 21, 2020

Technology Report: Artificial Intelligence 2019

In Artificial Intelligence at RSNA 2019, ITN Contributing Editor Greg Freiherr offers an overview of artificial...

‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›